Oxford Wealth Group »

Halozyme Therapeutics shares owned by Oxford Wealth Group

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Oxford Wealth Group from 13F filings

Historical chart of Oxford Wealth Group investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Oxford Wealth Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Oxford Wealth Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $449k 6.7k 67.30

More positions owned by Oxford Wealth Group

Invesco Exchange Traded Fd T S&p Mdcp Momntum (XMMO)
Invesco Exch Traded Fd Tr Ii S&p 500 Momntm (SPMO)
Invesco Exchange Traded Fd T S&p 500 Top 50 (XLG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ea Series Trust Bridgeway Blue (BBLU)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
First Tr Exchange-traded Ft Vest Ris (RDVI)
Invesco Exch Traded Fd Tr Ii S&p 500 Revenue (RWL)
Ishares Tr Msci Usa Mmentm (MTUM)
Meta Platforms Cl A (META)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
First Tr Exchange Traded Rba Indl Etf (AIRR)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Index Fds Growth Etf (VUG)
First Tr Exchange Traded Nasdq Cln Edge (GRID)

View all positions for Oxford Wealth Group

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Invesco
Arrowstreet Capital, Limited Partnership
D. E. Shaw & Co
Geode Capital Management
Snyder Capital Management
Dimensional Fund Advisors
Alliancebernstein
Norges Bank Investment Management
William Blair Investment Management
Federated Investors
Jupiter Asset Management
Wells Fargo & Company

View all funds holding Halozyme Therapeutics